Shun Lu

Also affiliated with Guangzhou University of Chinese Medicine, Shanghai Jiao Tong University, Shanghai Chest Hospital, Shanghai Cancer Institute, ZheJiang Academy of Agricultural Sciences, Ningbo University Affiliated Hospital, Hôpital de la Timone, Ningbo First Hospital, Weifang University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression”.

LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression

Annals of Oncology(2023)10.1016/j.annonc.2023.10.053

N/A

0.966DataRank · unranked

19 citations

Patrick M. Forde, J.D. Spicer, C. Wang, Shun Lu, Tetsuya Mitsudomi +15 more